| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/29/2005 | US20050214856 Nucleotide sequences coding bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 09/29/2005 | US20050214846 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/29/2005 | US20050214845 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 09/29/2005 | US20050214844 Nucleotide sequences coding translocation protein for use in identifying modulators for prevention and treatment of cell proliferative ,inflammatory and autoimmune disorders |
| 09/29/2005 | US20050214819 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/29/2005 | US20050214813 Amyloid-beta protein aggregation-regulating factors |
| 09/29/2005 | US20050214795 Polypeptide for use as diagnostic indicator of cell proliferative disorders; immunotherapeutics; antitumor agents |
| 09/29/2005 | US20050214794 Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for alstroem syndrome |
| 09/29/2005 | US20050214790 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of schizophrenia |
| 09/29/2005 | US20050214780 Using polymorphism in potassium channel interacting protein (KChIP1) as diagnostic indicator for pancreatic disorders |
| 09/29/2005 | US20050214762 Receptor binding domains of leptin; proteolysis; fusion proteins |
| 09/29/2005 | US20050214740 Device for measuring extracellular potential and manufacturing method of the same |
| 09/29/2005 | US20050214739 Expression of G protein coupled receptors in yeast |
| 09/29/2005 | US20050214738 Animal models comprising rapamycin binding (FRB) domain and target of rapamycin (TOR) sequence for use in identifying modulators of cellular pathways |
| 09/29/2005 | US20050214321 Recombinant icosahedral virus like particle production in pseudomonads |
| 09/29/2005 | US20050214314 Human cytokine receptor |
| 09/29/2005 | US20050214306 Surface proteins of leptospira |
| 09/29/2005 | US20050214300 Methods for treating cancer using Porimin as a target |
| 09/29/2005 | US20050214293 Containing heavy and light chain complementarity determining region 1,2 and 3 components of amino acid sequences 1-6; reduced immunogenicity; increased affinity and avidity; improved cell culturing |
| 09/29/2005 | US20050214281 G-protein coupled receptor |
| 09/29/2005 | US20050214253 Interferon-beta fusion proteins and uses |
| 09/29/2005 | US20050214252 Chordin-like molecules and uses thereof |
| 09/29/2005 | CA2795418A1 Improved bacterial host cell for the direct expression of peptides |
| 09/29/2005 | CA2559280A1 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
| 09/29/2005 | CA2559211A1 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 09/29/2005 | CA2558635A1 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
| 09/29/2005 | CA2557295A1 Improved bacterial host cell for the direct expression of peptides |
| 09/29/2005 | CA2555109A1 Methods of refolding mammalian glycosyltransferases |
| 09/29/2005 | CA2538293A1 Substances k01-0509 and process for producing the same |
| 09/28/2005 | EP1580272A2 TAT transdominant variants of human immunodeficiency virus (HIV) |
| 09/28/2005 | EP1578992A2 Methods of determining precise herg interactions and aletring compounds based on said interactions |
| 09/28/2005 | EP1578988A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 09/28/2005 | EP1578987A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 09/28/2005 | EP1578981A2 Tumor endothelial marker 7alpha molecules and uses thereof |
| 09/28/2005 | EP1578949A2 Site specific incorporation of keto amino acids into proteins |
| 09/28/2005 | EP1578917A2 Multimeric proteins and methods of making and using same |
| 09/28/2005 | EP1578914A2 Human ion channels |
| 09/28/2005 | EP1578912A2 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 09/28/2005 | EP1578911A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 09/28/2005 | EP1578905A2 Novel proteins and nucleic acids encoding same |
| 09/28/2005 | EP1578903A2 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| 09/28/2005 | EP1578902A2 Neurotransmission-associated proteins |
| 09/28/2005 | EP1578899A2 Secreted proteins |
| 09/28/2005 | EP1578802A1 Dna/rna transduction technology and its clinical and basic applications |
| 09/28/2005 | EP1578771A2 Remodeling and glycoconjugation of peptides |
| 09/28/2005 | EP1578760A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/28/2005 | EP1578461A2 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 09/28/2005 | EP1578385A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 09/28/2005 | EP1578380A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 09/28/2005 | EP1578372A2 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 09/28/2005 | EP1578368A2 Compositions and methods for the treatment of rheumatoid arthritis |
| 09/28/2005 | EP1578364A2 Compositions and methods for the treatmentof immune related diseases |
| 09/28/2005 | EP1578356A2 Assays to monitor amyloid precursor protein processing |
| 09/28/2005 | EP1578347A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/28/2005 | EP1578345A2 Peptides and antibodies to muc 1 proteins |
| 09/28/2005 | EP1578197A2 Composition and method for treating lupus nephritis |
| 09/28/2005 | EP1263787B1 G-protein coupled receptor |
| 09/28/2005 | EP1129194B1 Interleukin-1 homolog zil1a4 |
| 09/28/2005 | EP1037991B1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| 09/28/2005 | EP0836646B1 Ocean fish antifreeze peptides as food product additives |
| 09/28/2005 | CN1675366A Plastid genetic engineering via somatic embryogenesis |
| 09/28/2005 | CN1673744A Treatment and diagnosis of cancer |
| 09/28/2005 | CN1673741A Device for measuring extracellular potential and manufacturing method of the same |
| 09/28/2005 | CN1673378A Mammalian cell tandem affinity purification vector and method for purifying protein complex thereof |
| 09/28/2005 | CN1673376A Expression vector based on coronavirus proteolytic cleavage and its application |
| 09/28/2005 | CN1673372A A novel marnifi blue mold cell wall surface antigen II its coding sequence and application thereof |
| 09/28/2005 | CN1673371A A new marnifi blue mold cell wall surface antigen I, its coding sequence and application thereof |
| 09/28/2005 | CN1673343A Method for producing fodder protein by solid-solid state fermenting apple residues |
| 09/28/2005 | CN1673232A Receptor DR5 monoclonal antibody (AD5-10) resisting human tumor necrosin related apoptosis inducing ligand and its prepn and use |
| 09/28/2005 | CN1220703C Method for stabilising proteins in complex mixtures during thier storage in aqueous solvents |
| 09/28/2005 | CN1220521C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/27/2005 | US6950752 Methods for removing artifact from biological profiles |
| 09/27/2005 | US6949628 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection |
| 09/27/2005 | US6949627 a purified polyclonal or monoclonal antibody which recognizes an epitope of a surface protein of a merozoite of Plasmodium falciparum; capable of inducing a resistance to the parasite so it can be used as a vaccine |
| 09/27/2005 | US6949626 Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor |
| 09/27/2005 | US6949624 mediates the assembly of transcription repressor complexes by altering chromatin structure |
| 09/27/2005 | US6949380 culturing a proliferating epidermal basal cell population, exposing the cell(s) to fetuin, noggin, chordin, gremlin, follistatin, growing the cell(s) in the presence of an antisense oligonucleotide antagonist of bone morphogenetic protein (BMP) |
| 09/27/2005 | US6949372 Engineering intracellular sialylation pathways |
| 09/27/2005 | US6949366 Complexing; purified polypeptide |
| 09/27/2005 | US6949364 An isolated DNA encoding a protein, has testicular differentiation activity |
| 09/27/2005 | US6949361 Polynucleotide |
| 09/27/2005 | US6949360 DNA coding for human cell surface antigen |
| 09/27/2005 | US6949357 Reagents and methods useful for detecting diseases of the urinary tract |
| 09/27/2005 | US6949353 capable of acting as an guanylyltransferase and methyltransferase consisting of a polypeptide from the N-terminus of flavivirus genus RNA-dependent RNA polymerase |
| 09/27/2005 | US6949337 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it |
| 09/27/2005 | US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections |
| 09/27/2005 | US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates |
| 09/27/2005 | CA2149120C Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/27/2005 | CA2099612C Monokine mig induced by ifn-gamma |
| 09/22/2005 | WO2005087942A1 Process for expresson of foreign genes in methylotrophic bacteria through chromosomal integration |
| 09/22/2005 | WO2005087940A1 Genetically altered microorganisms with modified metabolism |
| 09/22/2005 | WO2005087810A2 Dimeric fusion proteins and materials and methods for producing them |
| 09/22/2005 | WO2005087802A2 Process for producing polypeptides |
| 09/22/2005 | WO2005086794A2 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor |
| 09/22/2005 | WO2005086595A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna |
| 09/22/2005 | WO2005058946A3 Methods for enhancing expression of recombinant proteins |
| 09/22/2005 | WO2004058147A3 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 09/22/2005 | US20050209448 Secretion, transcription and sporulation genes in bacillus clauslii |
| 09/22/2005 | US20050209447 Process for producing recombinant protein |
| 09/22/2005 | US20050209441 Using human serum albumin refolding ligand as tool in reanaturation of recombinant serum proteins |